CN Patent

CN102482670B — 通过抑制‘hsp70-相互作用蛋白的c末端’(chip)的天然反义转录物而治疗chip相关疾病

Assigned to Opko Curna LLC · Expires 2018-06-15 · 8y expired

What this patent protects

本发明涉及调节‘HSP70‑相互作用蛋白的C末端’(CHIP)的表达和/或功能的反义寡核苷酸，尤其是，通过靶向‘HSP70‑相互作用蛋白的C末端’(CHIP)的天然反义多核苷酸。本发明还涉及这些反义寡核苷酸的鉴定和它们在治疗CHIP表达相关的疾病和病症中的用途。

USPTO Abstract

本发明涉及调节‘HSP70‑相互作用蛋白的C末端’(CHIP)的表达和/或功能的反义寡核苷酸，尤其是，通过靶向‘HSP70‑相互作用蛋白的C末端’(CHIP)的天然反义多核苷酸。本发明还涉及这些反义寡核苷酸的鉴定和它们在治疗CHIP表达相关的疾病和病症中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102482670B
Jurisdiction
CN
Classification
—
Expires
2018-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Opko Curna LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.